4.6 Review

DNA methylation and cellular reprogramming

期刊

TRENDS IN CELL BIOLOGY
卷 20, 期 10, 页码 609-617

出版社

ELSEVIER SCIENCE LONDON
DOI: 10.1016/j.tcb.2010.08.003

关键词

-

资金

  1. National Institutes of Health [R37 CA 082422, R01 CA 83867]
  2. NATIONAL CANCER INSTITUTE [R37CA082422, R01CA083867] Funding Source: NIH RePORTER

向作者/读者索取更多资源

The recent discovery that a small number of defined factors are sufficient to reprogram somatic cells into pluripotent stem cells has significantly expanded our knowledge of the plasticity of the epigenome. In this review we discuss some aspects of cell fate plasticity and epigenetic alterations, with emphasis on DNA methylation during cellular reprogramming. Recent data suggest that DNA methylation is a major barrier to induced pluripotent stem (iPS) cell reprogramming. The demethylating agent 5-azacytidine can enhance the efficiency of iPS cells generation and the putative DNA demethylase protein activation-induced cytidine deaminase (AID/AICDA) can erase DNA methylation at pluripotency gene promoters, thereby allowing cellular reprogramming. Elucidation of the epigenetic changes taking place during cellular reprogramming will enhance our understanding of stem cell biology and facilitate therapeutic applications.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据